Authors:
IKEDA K
SAITOH S
SUZUKI Y
KOBAYASHI M
TSUBOTA A
FUKUDA M
KOIDA I
ARASE Y
CHAYAMA K
MURASHIMA N
KUMADA H
Citation: K. Ikeda et al., RELATIONSHIP OF HEPATOCELLULAR CARCINOGENESIS WITH PRECORE MUTANT VIRUS AND SERUM HEPATITIS-B VIRUS-DNA CONCENTRATION - A LONGITUDINAL ANALYSIS OF PATIENTS WITH CIRRHOSIS, Hepatology research, 10(2), 1998, pp. 142-155
Authors:
KOBAYASHI M
KUMADA H
ARASE Y
CHAYAMA K
KOBAYASHI M
TSUBOTA A
KOIDA I
SAITOH S
SUZUKI Y
MURASHIMA N
IKEDA K
MIYANO Y
MIZOSHITA K
MATSUDA M
KOIKE H
HASHIMOTO M
Citation: M. Kobayashi et al., USEFULNESS OF HEPATITIS-C VIRUS-RNA COUNTS BY 2ND-GENERATION HCV BDNA-PROBE IN CHRONIC HEPATITIS-C BASED ON THE HCV GENOTYPE, Journal of gastroenterology, 33(2), 1998, pp. 223-228
Authors:
KOBAYASHI M
CHAYAMA K
FUKUDA M
TSUBOTA A
SUZUKI Y
ARASE Y
KOIDA I
SAITOH S
MURASHIMA N
IKEDA K
KOIKE H
HASHIMOTO M
MIYANO Y
KOBAYASHI M
KUMADA H
Citation: M. Kobayashi et al., BIOCHEMICAL AND HISTOLOGICAL FEATURES OF HEPATITIS-G VIRUS-INFECTION, Journal of gastroenterology and hepatology, 13(8), 1998, pp. 767-772
Authors:
FUKUDA M
CHAYAMA K
TSUBOTA A
KOBAYASHI M
HASHIMOTO M
MIYANO Y
KOIKE H
KOBAYASHI M
KOIDA I
ARASE Y
SAITOH S
MURASHIMA N
IKEDA K
KUMADA H
Citation: M. Fukuda et al., PREDICTIVE FACTORS IN ERADICATING HEPATITIS-C VIRUS USING A RELATIVELY SMALL DOSE OF INTERFERON, Journal of gastroenterology and hepatology, 13(4), 1998, pp. 412-418
Authors:
CHAYAMA K
SUZUKI Y
KOBAYASHI M
KOBAYASHI M
TSUBOTA A
HASHIMOTO M
MIYANO Y
KOIKE H
KOBAYASHI M
KOIDA I
ARASE Y
SAITOH S
MURASHIMA N
IKEDA K
KUMADA H
Citation: K. Chayama et al., EMERGENCE AND TAKEOVER OF YMDD MOTIF MUTANT HEPATITIS-B VIRUS DURING LONG-TERM LAMIVUDINE THERAPY AND RE-TAKEOVER BY WILD-TYPE AFTER CESSATION OF THERAPY, Hepatology, 27(6), 1998, pp. 1711-1716
Authors:
IKEDA K
SAITOH S
SUZUKI Y
KOBAYASHI M
TSUBOTA A
KOIDA I
ARASE Y
FUKUDA M
CHAYAMA K
MURASHIMA N
KUMADA H
Citation: K. Ikeda et al., DISEASE PROGRESSION AND HEPATOCELLULAR CARCINOGENESIS IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS - A PROSPECTIVE OBSERVATION OF 2215 PATIENTS, Journal of hepatology, 28(6), 1998, pp. 930-938
Authors:
IKEDA K
KUMADA H
SAITOH S
SUZUKI Y
KOBAYASHI M
TSUBOTA A
KOIDA I
FUKUDA M
ARASE Y
CHAYAMA K
MURASHIMA N
TANGO T
Citation: K. Ikeda et al., A RANDOMIZED CONTROLLED TRIAL OF INTERFERON-ALPHA IN PATIENTS WITH CIRRHOSIS CAUSED BY 2A 2B GENOTYPE HEPATITIS-C VIRUS/, Journal of hepatology, 28(5), 1998, pp. 910-911
Authors:
TSUBOTA A
KUMADA H
TAKAKI K
CHAYAMA K
KOBAYASHI M
KOBAYASHI M
SUZUKI Y
SAITOH S
ARASE Y
MURASHIMA N
IKEDA K
Citation: A. Tsubota et al., DELETIONS IN THE HEPATITIS-B VIRUS CORE GENE MAY INFLUENCE THE CLINICAL OUTCOME IN HEPATITIS-B E-ANTIGEN POSITIVE ASYMPTOMATIC HEALTHY CARRIERS, Journal of medical virology, 56(4), 1998, pp. 287-293
Authors:
IKEDA K
SAITOH S
SUZUKI Y
KOBAYASHI M
TSUBOTA A
FUKUDA M
KOIDA I
ARASE Y
CHAYAMA K
MURASHIMA N
KUMADA H
Citation: K. Ikeda et al., INTERFERON DECREASES HEPATOCELLULAR CARCINOGENESIS IN PATIENTS WITH CIRRHOSIS CAUSED BY THE HEPATITIS-B VIRUS - A PILOT-STUDY, Cancer, 82(5), 1998, pp. 827-835
Authors:
CHAYAMA K
MENON J
OKAMOTO K
HASHIMOTO M
TSUBOTA A
KOBAYASHI M
MIYANO Y
KOIKE H
KOBAYASHI M
KOIDA I
ARASE Y
SAITOH S
SUZUKI Y
MURASHIMA N
IKEDA K
KUMADA H
Citation: K. Chayama et al., NUCLEOTIDE-SEQUENCES OF HEPATITIS GB VIRUS-C - IDENTIFICATION OF HIGHLY CONSERVED DOMAINS IN THE 5'-NONCODING REGION AND DETECTION BY POLYMERASE CHAIN-REACTION, HEPATOLOGY RESEARCH, 6(5), 1997, pp. 225-232
Authors:
IKEDA K
SAITOH S
SUZUKI Y
TSUBOTA A
KOIDA I
KOBAYASHI M
ARASE Y
CHAYAMA K
MURASHIMA N
KUMADA H
Citation: K. Ikeda et al., EFFECT OF ARTERIAL ADMINISTRATION OF A HIGH-MOLECULAR-WEIGHT ANTITUMOR AGENT, STYRENE-MALEIC ACID NEOCARZINOSTATIN, FOR MULTIPLE SMALL LIVER-CANCER - A PILOT-STUDY, Journal of gastroenterology, 32(4), 1997, pp. 513-520
Authors:
KOBAYASHI M
CHAYAMA K
ARASE Y
FUKUDA M
TSUBOTA A
SUZUKI Y
KOIDA I
SAITOH S
MURASHIMA N
IKEDA K
KOIKE H
HASHIMOTO M
MIYANO Y
KOBAYASHI M
KUMADA H
Citation: M. Kobayashi et al., HEPATITIS-G VIRUS-INFECTION AFTER BLOOD-TRANSFUSION IN PATIENTS WITH CHRONIC LIVER-DISEASE TREATED SURGICALLY FOR HEPATOCELLULAR-CARCINOMA, International hepatology communications, 9(1), 1997, pp. 28-36
Authors:
IKEDA K
SAITOH S
SUZUKI Y
KOIDA I
TSUBOTA A
KOBAYASHI M
ARASE Y
CHAYAMA K
MURASHIMA N
KUMADA H
Citation: K. Ikeda et al., A PROSPECTIVE RANDOMIZED ADMINISTRATION OF 5'-DEOXY-5-FLUOROURIDINE AS ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION, American journal of clinical oncology, 20(2), 1997, pp. 202-208
Authors:
CHAYAMA K
TSUBOTA A
KOBAYASHI M
OKAMOTO K
HASHIMOTO M
MIYANO Y
KOIKE H
KOBAYASHI M
KOIDA I
ARASE Y
SAITOH S
SUZUKI Y
MURASHIMA N
IKEDA K
KUMADA H
Citation: K. Chayama et al., PRETREATMENT VIRUS LOAD AND MULTIPLE AMINO-ACID SUBSTITUTIONS IN THE INTERFERON SENSITIVITY-DETERMINING REGION PREDICT THE OUTCOME OF INTERFERON TREATMENT IN PATIENTS WITH CHRONIC GENOTYPE 1B HEPATITIS-C VIRUS-INFECTION, Hepatology, 25(3), 1997, pp. 745-749
Authors:
TSUBOTA A
KUMADA H
CHAYAMA K
ARASE Y
SAITOH S
KOIDA I
SUZUKI Y
KOBAYASHI M
MURASHIMA N
IKEDA K
Citation: A. Tsubota et al., TIME-COURSE OF HISTOLOGICAL-CHANGES IN PATIENTS WITH A SUSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-C VIRUS-INFECTION, Journal of hepatology, 27(1), 1997, pp. 49-55
Authors:
IKEDA K
CHAYAMA K
SAITOH S
KOIDA I
SUZUKI Y
TSUBOTA A
KOBAYASHI M
ARASE Y
MURASHIMA N
KUMADA H
Citation: K. Ikeda et al., HEPATITIS-C VIRUS SUBTYPE 3B INFECTION IN A HOSPITAL IN JAPAN - EPIDEMIOLOGIC-STUDY, Journal of gastroenterology, 31(6), 1996, pp. 801-805
Authors:
ARASE Y
CHAYAMA K
TSUBOTA A
MURASHIMA N
SUZUKI Y
KOIDA I
KOBAYASHI M
SAITOH S
IKEDA K
KUMADA H
KOBAYASHI M
SUZUKI H
Citation: Y. Arase et al., A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF NATURAL INTERFERON-BETA THERAPY FOR E-ANTIGEN-NEGATIVE CHRONIC HEPATITIS-B PATIENTS WITH ABNORMAL TRANSAMINASE LEVELS, Journal of gastroenterology, 31(4), 1996, pp. 559-564
Authors:
CHAYAMA K
TSUBOTA A
KOBAYASHI M
HASHIMOTO M
MIYANO Y
KOIKE H
KOBAYASHI M
KOIDA I
ARASE Y
SAITOH S
MURASHIMA N
IKEDA K
KUMADA H
Citation: K. Chayama et al., A PILOT-STUDY OF CORTICOSTEROID PRIMING FOR LYMPHOBLASTOID INTERFERON-ALFA IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 23(5), 1996, pp. 953-957
Authors:
TSUBOTA A
KUMADA H
CHAYAMA K
ARASE Y
SAITOH S
KOIDA I
MURASHIMA N
SUZUKI Y
KOBAYASHI M
TAKAGI K
KOBAYASHI M
IKEDA K
Citation: A. Tsubota et al., RELATIONSHIP BETWEEN PRETREATMENT VIREMIA LEVEL AND RESPONSE TO INTERFERON-ALPHA THERAPY IN CHRONIC HEPATITIS-C DIFFERS IN VIRAL TYPE-1 ANDTYPE-2 INFECTIONS, Digestive diseases and sciences, 41(10), 1996, pp. 1925-1932
Authors:
SUZUKI F
CHAYAMA K
KOBAYASHI M
TSUBOTA A
KOIDA I
SAITOH S
ARASE Y
MURASHIMA N
IKEDA K
KUMADA H
Citation: F. Suzuki et al., NOVEL HEPATITIS-B VARIANTS IN SIBLING CARRIERS POSITIVE FOR ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN, HEPATOLOGY RESEARCH, 4(3), 1995, pp. 121-125
Authors:
ARASE Y
KUMADA H
CHAYAMA K
NAOYA M
TSUBOTA A
KOIDA I
KOBAYASHI M
SUZUKI Y
IKEDA K
SAITOH S
KOBAYASHI M
Citation: Y. Arase et al., USEFULNESS OF HCV-RNA COUNTS BY THE METHOD OF HCV-BDNA PROBE IN INTERFERON RETREATMENT FOR PATIENTS WITH HCV-RNA POSITIVE CHRONIC HEPATITIS-C, HEPATOLOGY RESEARCH, 4(1), 1995, pp. 19-25
Authors:
IKEDA K
SAITOH S
KOIDA I
TSUBOTA A
ARASE Y
CHAYAMA K
KUMADA H
Citation: K. Ikeda et al., A PROSPECTIVE RANDOMIZED EVALUATION OF A COMPOUND OF TEGAFUR AND URACIL AS AN ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA TREATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION, American journal of clinical oncology, 18(3), 1995, pp. 204-210